baber/WOPTO huggingface dataset:
Patent CA-2497804-A1 (CA)
Title: Anticorps mcp-1 anti-humain d'origine humaine et fragment d'anticorps correspondant
Inventor: NISHIHARA TSUKASA
IPC: C07K16/24
Filed: 2003-09-10
Abstract: L'invention concerne des matières efficaces pour traiter des immunopathies dans lesquelles intervient le MCP-1. A l'aide de la méthode des anticorps présentés à la surface des phages, on obtient scFv, qui présente une affinité élevée pour le MCP-1 humain. Sur la base des données concernant la chaîne VH et la chaîne VL obtenues à partir de scFv, on produit un anticorps MCP-1 anti-humain d'origine humaine et un fragment d'anticorps anti-humain d'origine humaine. L'anticorps et le fragment d'anticorps sont présumés utiles pour traiter l'inflammation et les immunopathies provoquées par le MCP-1.
Patent CA-2499881-A1 (CA)
Title: Credit card case with quick-release latch
Inventor: NELMS DAVID W
IPC: A45F5/02
Filed: 2003-10-09
Abstract: A credit card case (10)or fob with an integrated quick-release latch (24) is provided that may be unclipped readily from a key loop, key chain or other device. The quick-release credit card case (10) includes upper (12) and lower (14) cover portions and a pivot member for connecting the upper and lower cover portions. The pivot member is adapted to have at least one card mounted thereon so as to permit pivotal rotation of the card (16) relative to the upper and lower (14) cover portions. The upper (12) and lower (14) cover portions each have a slot (22) in an outer surface thereof at mateably aligned locations to permit insertion of a key chain loop therein. A latch (24) mounted on at least one of the cover portions (12, 14) is selectively movable to alternate positions exposing the radially outwardly facing opening of the slot (22) in said cover portions (12, 14) and closing said radially outwardly facing opening of the slot (22) in said cover portions (12, 14).
Patent CA-2499979-A1 (CA)
Title: Immediate release dosage form comprising shell having openings therein
Inventor: MCNALLY GERARD P
IPC: A61K9/00
Filed: 2003-03-21
Abstract: The invention provides an immediate release dosage form having a solid core and a shell readily soluble in gastrointestinal fluids. The dosage form also comprises one or more openings in the shell.
Patent CA-2500112-A1 (CA)
Title: Real time total asset visibility system
Inventor: GHAFFARI TOURAJ
IPC: G06Q10/00
Filed: 2002-10-16
Abstract: The monitoring system of the present invention includes one or more host controllers generally indicated as (14) which is disposed in communicating relation with anyone or all of the plurality of monitored locales (10) through (13). The host controller (14) may be in the form of a somewhat conventional PC, or other processor/computer facility (16) and is utilized to accomplish higher level processing in order to filter the data received from the remainder of the operative components of the monitoring system of the present invention and thereby maintain adequate inventory control and/or perform tracking procedures, as set forth above.
Patent CA-2501942-A1 (CA)
Title: Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents
Inventor: GALAL AHMED M
IPC: C07D519/00
Filed: 2003-10-09
Abstract: This invention relates to a compound of the formula where R is or of the formula: The invention also relates to the use of these compounds in pharmaceutical compositions as anticancer and anti-infective agents.
Patent CA-2506145-A1 (CA)
Inventor: ROBERTSON DAVID
IPC: B65D47/34
Filed: 2005-04-28
Abstract: A pump bottle flow control apparatus consists of a bottle and pump combination. The bottle has a bottom and a peripheral side wall that rises from the bottom terminating at its upper extremity in a top opening. The bottle has an interior sump, serving as a lowermost portion of the bottle into which liquid flows by force of gravity. The pump is secured to the top opening of the bottle. The pump has a manual actuator and a rigid supply tube that extends into the bottle and terminates within the interior sump.
Patent CA-2508422-A1 (CA)
Title: Method for controlling pests using magnetically polarizable metallic particles
Inventor: HOWSE PHILIP
IPC: A01N25/24
Filed: 2003-12-05
Abstract: There is disclosed a method of controlling pests which comprises exposing a surface of the pest to a particulate composition containing particles of an initially unmagnetized material, which is capable of becoming magnetically polarized when subjected to an electric or magnetic field, the said particles being associated with at least one pesticide or behaviour modifying chemical.
Patent CA-2510922-A1 (CA)
Inventor: KNOPECK GARY
IPC: B08B3/08
Filed: 2003-12-16
Abstract: La présente invention concerne des compositions et des procédés de nettoyage d'articles contaminés fondés sur la fourniture d'une composition zéotropique comprenant (a) au moins un solvant inflammable possédant un point d'ébullition à une première pression, (b) au moins un premier solvant ininflammable possédant un point d'ébullition à cette première pression qui est inférieur aux alentours du point d'ébullition à cette première pression du solvant inflammable et, (c) au moins un second solvant ininflammable possédant un point d'ébullition à cette première pression qui est supérieur aux alentours du point d'ébullition à cette première pression du solvant inflammable.
Patent CA-2512083-A1 (CA)
Title: Glass-ceramic material and method of making
Inventor: SCHWEIGER MICHAEL J
IPC: C04B37/02
Filed: 2003-12-23
Abstract: The present invention is a glass-ceramic material and method of making usefu l for joining a solid ceramic component and at least one other solid component . The material is a blend of M1-M2-M3-M4, wherein M1 is BaO, SrO, CaO, MgO, or combinations thereof, M2 is Al2O3, present in the blend in an amount from 2 to 15 mol%, M3 is SiO2 with up to 50 mol% B203 and a metal oxide selected from the group of La2O3, Y2O3, Nd2O3 or combinations thereof, or between 0.1 and 7.5 mol% K2O. In the case of a metal oxide from the group La2O3, Y2O3, Nd2O3 or combinations thereof, it is preferred that the composition contain an additional 0.1 to 3 mol %CuO. In all cases, the glass ceramic material in a crystalline phase substantially matches a coefficient of thermal expansion o f solid electrolytes having a thermal expansion coefficient of 12 x 10-6 ~C-1 as measured from 25 ~C to 1000 ~C, and does not degrade with repeated heat cycling. According to the present invention, the series of glass ceramics in the M1-Al2O3-M3-M4 system can be used to join or seal both tubular and plana r solid oxide fuel cells, oxygen electrolyzers, and membrane reactors for the production of syngas, commodity chemicals and other products.
Patent CA-2512299-A1 (CA)
Inventor: DANDURAND JULES
IPC: B62D55/26
Filed: 2005-07-15
Abstract: The present invention provides an endless track belt allowing an enhanced traction of a tracked vehicle over a range of surface conditions, by providing tread of a non-uniform section.
Patent CA-2513325-A1 (CA)
Title: Detergent composition
Inventor: PAUL SUDIPTO KUMAR
IPC: A61Q19/10
Filed: 2004-01-23
Abstract: A cleansing cosmetic composition comprising; i) a cationised silicon delivery system selected from one or more of a) a cationised fatty alkyl silicone copolymer; b) a cationised dimethiconol complex and c) a cationised high viscosity lower alkyl silicone fluid with or without cationised silicone gum blend; and ii) detergent active. Also disclosed is a cationised silicone delivery system comprising: a) 15 - 50 parts of a cationised fatty alkyl silicone copolymer; b) 5 - 50 parts of a cationised dimethiconol complex; and c) 1 - 50 parts of a cationised high viscosity lower alkyl silicone fluid with cationised silicone gum blend.
Patent CA-2513569-A1 (CA)
Inventor: HARVEY PETER
IPC: G01V1/20
Filed: 2004-01-20
Abstract: The apparatus (40) has a sensor (41) disposed on the first end (42) of an elongate connector (43) by means of fixed interface link (79). A recorder unit (44) is disposed on the second end (45) of the connector (43) opposite the first end (42). The connector (43) is bendable within a predefined curvature range. When the apparatus (40) is deployed into the sea, it is adapted to free-fall through the body of water and to land on the seafloor such that the sensor (41) is spaced apart from the recorder unit (44). The length of the connector (43) is dynamically variable within a predefined range so as to eradicate or minimise coupling of any vibration of the recorder unit (44) to the sensor (41). The physical separation of the sensor (41) and the recorder unit (44), together with the mechanical characteristics of the connector (43), ensure that the sensor (41) is substantially vibrationally de-coupled from the recorder unit (44). In other words, the mass of the recorder unit (44) does not inhibit the sensor (41) from responding to seismic waves, and any vibration of the recorder unit (44) (for example due to any water currents that may be flowing in the vicinity of the recorder unit (44) ) is not substantially transmitted to the sensor (41). Hence, the connector (43) constitutes a positive mechanical connection between the sensor (41) and the recorder unit (44) so far as maximum separation distance is concerned, however not so far as seismic or flow induced vibrations are concerned.
Patent CA-2514749-A1 (CA)
Title: Event-triggered data collection
Inventor: SHEYNBLAT LEONID
IPC: H04B17/00
Filed: 2004-01-30
Abstract: A method of obtaining data useful for one or more network applications is described. The method is performed responsive to a triggering event, such as a dropped call, a position fix, or even expiration of a timer. A position estimate for a subscriber station is obtained responsive to the event. A  record is then formed associating the position estimate for the subscriber station with an identifier of the triggering event and/or data measured or obtained responsive to the event, such as the strength of one or more pilots visible to the subscriber station. The record is either stored locally or transmitted to a remote location. In one implementation, the record is transmitted to a remote location, and stored in a database holding like records relating to other subscriber stations.
Patent CA-2516569-A1 (CA)
Inventor: LEE MIN-HEE
IPC: C08K3/34
Filed: 2004-02-18
Abstract: The present invention relates to the foams of the polyvinyl chloride nanocomposites comprising of polyvinyl chloride, layered inorganic compounds, and foaming agents. They are effective in that they have superior mechanical strength and non-flammability even with a low specific gravity; demonstrate a high foaming efficiency even with a small amount of a foaming agent; and have an even microcellular structure.
Patent CA-2516846-A1 (CA)
Inventor: KAVALEW DALE GARY
IPC: D04H1/26
Filed: 2004-02-25
Abstract: Fibrous structures, especially fibrous structures incorporated into facial tissue, toilet tissue and paper towel and napkin products, that comprise a fiber having a length of from about 0.4 mm to about 1.2 mm and a coarseness of from about 3.0 mg/100 m to about 7.5 mg/100 m , wherein the fibrous structures exhibit a lint value of greater than about 3.5 to about 15, and processes for making such fibrous structures are provided.
Patent CA-2517242-A1 (CA)
Inventor: THOMPSON BENNIE
IPC: A61B17/00
Filed: 2004-02-24
Abstract: A biopsy device (20) having a translating and rotating cutter (104) disposed within an outer cannula (80) is disclosed. The translational speed of the cutter (104) is varied using a variable pitch member (142). The variable pitch member (142) can include a shaft having a relatively coarse threaded portion (146) for rapid cutter advance and a relatively finer threaded portion (148) for cutter advance during tissue severing.
Patent CA-2517439-A1 (CA)
Title: Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
Inventor: PATTI JOSEPH M
IPC: A61K47/48
Filed: 2004-03-04
Abstract: Immunogenic polysaccharide-protein conjugates having a polysaccharide antigen (or its oligosaccharide fragment representing one or more antigenic epitopes) derived from a nosocomial pathogen conjugated to a staphylococcal surface adhesin carrier protein are used in immunogenic compositions to elicit antibody responses to both the polysaccharide antigen and the staphylococcal surface adhesion carrier protein. Such immunogenic compositions are used to immunize against diseases caused by Staphylococcal aureus, Staphylococcal epidermidis or other nosocomial pathogens.
Patent CA-2518855-A1 (CA)
Title: Amusement device for game play and lottery game utilizing the amusement device
Inventor: STRING GREGORY F
IPC: A63F3/06
Filed: 2005-09-12
Abstract: An amusement device that is a game ticket in a lottery-type game is formed as a noisemaker that carries game indicia.      The device includes a sealed envelope or bag having indicia for game play in the bag, preferably printed or attached to an inner surface of the bag. The envelope is rupturable to open the envelope for game play and generate a popping noise for amusement.
Patent CA-2520391-A1 (CA)
Title: Novel cyclodextrin derivatives, method for the preparation thereof and use thereof for the solubilization of pharmacologically active substances
Inventor: CHMURSKI KAZIMIERZ
IPC: A61K47/48
Filed: 2004-03-22
Abstract: The invention relates to a compound corresponding to general formula (I) wherein n is a whole number from 1-6, m is a whole number equal to 5, 6 or 7, R1 is an OH group, all R1 s are identical, Z is an NHX group, X is a hydrogen atom, and R is a hydrogen atom or a bioidentification element, with the proviso that the compound wherein n=1, m=6, Z=NH2 and R1=OH is excluded.
Patent CA-2521833-A1 (CA)
Title: Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)
Inventor: VLAHOVA PETINKA IVANOVA
IPC: A61P19/10
Filed: 2002-05-21
Abstract: Novel crystalline forms of [R-(R*,R*))-2-(4-fluorophenyl)-.beta.,.DELTA.;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid hemi calcium salt atorvastatin designated Form V, Form VI, Form VII, Form VIII, Form IX, Form X, Form XI, Form XII, Form XIII, Form XIV, Form XV, Form XVI, Form XVII, Form XVIII, and Form XIX are characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, and Alzheimer's disease.
Patent CA-2523362-A1 (CA)
Inventor: PLATT TERENCE CHRISTOPHER
IPC: E05F15/00
Filed: 2004-04-26
Abstract: An edge device for an elevator door includes an elongate array of infrared transmitters and/or receivers and a proximate elongate array of illuminable elements, both arrays extending for a substantial part of the length of the door. The illuminable elements are adapted to be illuminated when the door is in motion. The two arrays are disposed in a common carrier structure, being either vertically interleaved or extending vertically in parallel with each other.
Patent CA-2524685-A1 (CA)
Title: Single ply tissue products surface treated with a softening agent
Inventor: WENDLER ROGER
IPC: B05B15/02
Filed: 2004-03-04
Abstract: Tissue products are described that have been topically treated with a chemical additive, such as a softener. The softener may be, for instance, a polysiloxane. The polysiloxane is topically applied to a tissue sheet, such as a single ply sheet, so as to form a Z-directional gradient in the sheet.  Particular, most of the polysiloxane remains on the surface of the tissue product as opposed to migrating to the center of the sheet. In this manner, tissue sheets are formed with improved softness at lower levels of polysiloxane and without the need for applying any surfactants to the sheet. A  system for applying chemical additives to tissue sheets is also described. The system includes a chemical additive applicator, such as a meltblown die that emits the chemical additive through a plurality of orifices. In one embodiment, the system includes a device for periodically cleaning the orifices during application of the chemical additive. The cleaning device may be, for instance, a brush that traverses across the die head when desired.
Patent CA-2525241-A1 (CA)
Inventor: SAUVAGEAU DAVID J
IPC: A61F2/06
Filed: 2004-05-18
Abstract: A surgical instrument comprises an elongated body member having a distal end and a head extending from the distal end of the elongated body member, with the head comprising a remotely actuatable needle driver and a needle catch. A  needle is adapted for receiving a suture and for being driven by the needle driver through a tissue into the needle catch, making a stitch. The instrument further comprises a remotely actuable implement, such as a push bar, for moving the needle from a first position lodged in the needle catch to a second position dislodged from or able to be readily dislodged from the needle catch.  The instrument may be used for placing multiple stitches without removing the instrument from the body. One particularly advantageous embodiment comprises a suturing device adapted for insertion in a body lumen, such as for attaching an endoluminal device to the lumen wall.
Patent CA-2526715-A1 (CA)
Inventor: FU CHUN
IPC: A47K13/22
Filed: 2003-05-30
Abstract: The invention relates to a sanitary device equipped on a toilet seat. The device is used mainly to solve the sanitary problem that, the seat ring of the toilet seat will contact with a lot of people's body, so virtually it becomes a spreading medium of the pathogen. The device comprises a seat frame, a mantle, a mantle recovery device and a turning cap. And the whole device is attached on the base of the toilet seat. An opening/closing part is provided at the fracture on the seat frame of the seat ring type or of the framed type.  The long and tubular mantle is put on the seat frame via the fracture, and then it moves around the seat frame by a round. At the connecting part that connects the seat frame with the base the mantle is cut open from the outer side by a blade. Subsequently, the mantle covers the other part of the seat frame. Finally, it comes into a recovery device via the fracture.  Consequently, the opening/closing part forms a completely circular seat frame as a conventional seat frame. And the seat frame's surface is fully covered by the one-off separating film. A referring sign is provided adjacent to the terminal end of the mantle, so as to remind the user of timely replacing the mantle. Depending on the different length of the mantle, a roll of mantle newly replaced can be used by 10-100 man-times. This device is simple in structure, sanitary, advantageous to environmental protection, convenient and practical. Furthermore, when the user sits on the device, he or she will feel comfortably. This device adapts to a variety of the spots where the toilet seat will not be used by only one specific person.
Patent CA-2526723-A1 (CA)
Title: Amplifier system for determining parameters of a patient
Inventor: DRAKULIC BUDIMIR
IPC: H03F3/45
Filed: 2004-05-27
Abstract: An electrode (12, 14) is attached at a selective position to a patient's body (11) to provide signals representative of the patient's parameters (e.g., electrocardiogram) at that position. The electrode signal may be in microvolts or millivolts. Electrode impedance may vary to approximately 200 kilohms. An amplifier (10, 16, 18, 34) having an input impedance (e.g., 1015ohms) approaching infinity and a low output impedance prevents signal-losses. A low pass filter connected to the amplifier output eliminates noise and passes signals at low frequencies (e.g., 1 kilohertz). The filter and the amplifier are disposed on a printed circuit board with the amplifier physically and electrically isolated from the filter. Another low pass filter may be connected to the input of the amplifier.
Patent CA-2528790-A1 (CA)
Inventor: O'BRIEN DENNIS
IPC: A61F2/958
Filed: 2004-05-27
Abstract: A catheter is provided having a system for anchoring an inflatable balloon at a treatment site. The system includes a flexible member having a substantially cylindrical shaped wall that defines a longitudinal axis. The outer surface of the cylindrical wall is formed with a plurality of protuberances that each project radially outward from the wall. With this structure, the wall seamlessly interconnects the protuberances together. In one embodiment, the flexible member constitutes a portion of a dilatation balloon. In another embodiment, the flexible member is formed as a jacket that is placed over and bonded to a dilatation balloon. The protuberances are sized, shaped and spaced on the wall of the flexible member to allow each protuberance to penetrate and become embedded in a lesion at a treatment site during inflation of the balloon. Once embedded, the protuberances anchor the balloon at the treatment site.
Patent CA-2530634-A1 (CA)
Title: Methods of treating obesity and related disorders using tellurium and selenium compounds
Inventor: RUBINSTEIN MENACHEM
IPC: A61K/
Filed: 2004-06-13
Abstract: The present invention relates to methods of using tellurium and selenium containing compounds, and particularly to the use of small organic molecules containing tellurium or selenium as exemplified by the compound ammonium-trichloro(dioxoethylene-O,O~)tellurate (known by the abbreviation AS101) for treating obesity and obesity related disorders or complications and for reducing of food intake.
Patent CA-2533504-A1 (CA)
Inventor: TEN BRINK JANNA ALBERDINA
IPC: C07C251/28
Filed: 2004-07-23
Abstract: The present invention provides optionally substituted compounds of the formula (I) or salts thereof; wherein R1 is O or S when double bonded to the ring or is OH, SH, or a protected equivalent, when single bonded to the ring, R2 is hydrogen or more preferably an C1-C10 organic group attached by a carbon atom, X is H, 0, 00, S or SS R3 is absent where X=H, is hydrogen or is a hydroxyl or thiol protecting group, R4 is a hetero- or preferably homo-cyclic aryl group, optionally substituted with a further group R5 and groups T1 are each, independently, absent, hydrogen or an S-R6 group, where any/each R6 is independently an organic group of molecular weight up to around 500 amu. The invention further provides a method for the synthesis of such compounds and a method of treatment comprising administering such compounds to a mammalian subject.